Crescent Biopharma, Inc. (CBIO)

NASDAQ

$12.19

$--

(0.00%)

Pre-Market

Crescent Biopharma, Inc. (CBIO) Live Price Chart

Last updated: ⁦2026-10-19 11:35:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Crescent Biopharma, Inc. (CBIO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $12.19, with a market capitalization of $439.82M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.72 to $27.41. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$439.82M
Open	$12.19
Day's High	$555.00
Day's Low	$2.83
Previous Close	$11.84
Volume	--
Average Volume	364.38K
P/E Ratio	--
52-Week High	$27.41
52-Week Low	$8.72
Dividend Yield	--
Earnings Date	--

Crescent Biopharma, Inc. (CBIO) Pre-Market Stock Price

Crescent Biopharma, Inc. (CBIO) is trading at $12.19 in pre-market trading as of 2026-10-19 08:29:00, up 2.96% ($0.35) from the previous close of $11.84

Pre-market trading shows how investors are pricing CBIO before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Crescent Biopharma, Inc. (CBIO) 7-Day Stock Price Change

Over the past seven days, Crescent Biopharma, Inc. (CBIO) moved from $14.12 to $12.19, representing a decline of 13.66% ($1.93).

The stock traded between $11.78 and $15.28 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 255.47 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

CBIO 52-Week Price Position

Position in Range: 18.6%

52W Low$8.72

52W High$27.41

CBIO is currently trading at $12.19, placing it 18.6% of the way from its 52-week low of $8.72 to its 52-week high of $27.41. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Crescent Biopharma, Inc. (CBIO)?

Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent's pipeline product CR-001 has the potential to deliver improved clinical efficacy and safety over pembrolizumab. CR-001 is a new molecular entity designed to replicate the functional properties of ivonescimab, a cooperative bispecific anti-PD-1/anti-VEGF antibody in development by Akeso Biopharma and Summit Therapeutics that delivered improved efficacy in a head-to-head Phase 3 clinical trial versus Keytruda in non-small cell lung cancer. The company focuses on advancing its second and third programs, CR-002 and CR-003, which are antibody drug conjugates (ADCs) against validated oncology targets.

Crescent Biopharma, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	44
Exchange	NASDAQ
Company Website	https://www.crescentbiopharma.com

How to Buy Crescent Biopharma, Inc. (CBIO) Stock on MEXC

Eligible investors can buy real shares of Crescent Biopharma, Inc. (CBIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CBIO and Place Your Order

Open the RealStocks trading page and search for CBIO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Crescent Biopharma, Inc. (CBIO) stock price today?

Crescent Biopharma, Inc. (CBIO) is currently trading at $ 12.19, up 2.96% ($0.35) from the previous close of $ 11.84. Intraday prices update in real time during regular trading hours.

2.Is CBIO stock going up or down today?

As of 2026-10-19 08:29:00, CBIO is trading at $ 12.19, up 2.96% ($0.35) from its previous close of $ 11.84. The stock has traded between $ 2.83 and $ 555.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is CBIO pre-market price?

As of 2026-10-19 08:29:00, CBIO is trading at $ 12.19 in pre-market trading, up 2.96% ($0.35) from the previous close of $ 11.84. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CBIO after-hours price?

As of 2026-10-19 08:29:00, CBIO is trading at $ 12.19 in after-hours trading, up 2.97% ($0.35) from the regular-session close of $ 11.84. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CBIO stock trading now?

CBIO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CBIO sit relative to its 52-week high and low?

Over the past 52 weeks, CBIO has traded between a low of $ 8.72 and a high of $ 27.41. At $ 12.19, the stock is positioned 18.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Crescent Biopharma, Inc. in?

Crescent Biopharma, Inc. (CBIO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Crescent Biopharma, Inc.'s market capitalization and where is it listed?

Crescent Biopharma, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 439.82M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CBIO valued in terms of P/E ratio and EPS?

CBIO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.93. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Crescent Biopharma, Inc. pay a dividend?

Crescent Biopharma, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.